Skip to main content
Free research Free research Free assay review with research home and workspace preview
Quick search ChEMBL 36
Assay Detail

CHEMBL5162350

Review assay metadata, readout intent, target linkage, and publication context from the same page.

Binding
Inhibition of HER2 V777L mutant (unknown origin) incubated for 120 mins in presence of 33P-ATP by P81 ion exchange cellulose chromatography
3
Total Activities
3
Compounds Tested
1
Activity Types
0
Assay Parameters

Assay Information

Assay Type Binding
Organism Homo sapiens
Confidence 9 — Direct single protein target
Curated By Autocuration

Target

Receptor tyrosine-protein kinase erbB-2 (CHEMBL1824)
Type SINGLE PROTEIN
Organism Homo sapiens

Publication

Discovery of SPH5030, a Selective, Potent, and Irreversible Tyrosine Kinase Inhibitor for HER2-Amplified and HER2-Mutant Cancer Treatment.
Li D, Tu Y, Jin K, Duan L, Hong Y, Xu J, Chen N, Zhang Z, Zuo H, Gong W, Zhang J, Wang Q, Qian H, Wang X, Ke Y, Xia G.
J Med Chem (2022) 65 : 5334 -5354
PubMed 35319895 · DOI

Activity Statistics

Type Count Avg pChEMBL Best pChEMBL
IC50 3 8.86 9.80

Compounds Tested

Compound Name Phase Activities Best pChEMBL
CHEMBL5178703 1 9.80
CHEMBL3647420 PYROTINIB 3.0 1 8.41
CHEMBL180022 NERATINIB 4.0 1 8.36

Activity Data

Compound Name Type Rel. Value Units pChEMBL
CHEMBL5178703 IC50 = 0.16 nM 9.80
CHEMBL3647420 PYROTINIB IC50 = 3.91 nM 8.41
CHEMBL180022 NERATINIB IC50 = 4.4 nM 8.36